Genor Biopharma Holdings Limited

HKEX:6998.HK

1.65 (HKD) • At close September 12, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) HKD.

2023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q1
Operating Activities:
Net Income -199.905-199.905-137.276-137.276-162.292-162.292-202.816-202.816-232.166-232.166-200.447-200.447-1,246.859-1,246.859-391.42-143.556-74.317
Depreciation & Amortization 22.22922.22913.87313.87311.50811.50814.07414.07414.32214.32215.02115.02112.92112.92111.96411.2669.552
Deferred Income Tax 0000-58.648-1.3550000000001.6110
Stock Based Compensation 11.88611.88618.56918.5693.7073.70720.41220.41221.95321.95345.18445.18436.42536.425157.64427.1310
Change In Working Capital -7.639-7.6390039.14739.14700-4.594-4.59400-101.192-101.1921.1428.385-9.58
Accounts Receivables 00000000000000000.042
Change In Inventory 3.9533.95300-2.353-2.35300-11.17-11.1700-3.83-3.83-1.671.67-3.025
Change In Accounts Payables 00000000000000000
Other Working Capital -11.592-11.5920041.49941.499006.5766.57600-97.362-97.3622.8126.715-6.555
Other Non Cash Items 76.21676.216-10.512-10.512-24.77-24.7712.22712.22741.79641.796-12.939-12.9391,117.8441,117.844-109.062-0.098-0.289
Operating Cash Flow -97.214-97.214-115.346-115.346-132.7-132.7-156.104-156.104-158.69-158.69-153.181-153.181-180.861-180.861-329.732-95.261-74.634
Investing Activities:
Investments In Property Plant And Equipment 0.3760.376-0.893-0.8930.2120.212-4.732-4.732-9.787-9.787-13.448-13.448-9.48-9.48-3.926-8.209-7.708
Acquisitions Net 003.10-0.147000000000000
Purchases Of Investments 00000000000000000
Sales Maturities Of Investments 00000000000000000
Other Investing Activites 2.142.141.3711.371-1.503-1.503-0.448-0.448-1.442-1.442-2.454-2.454-34.291-34.2911.3930.04-0.13
Investing Cash Flow 2.5162.5160.4780.478-1.291-1.291-5.18-5.18-11.228-11.228-15.902-15.902-43.771-43.771-2.533-8.169-7.708
Financing Activities:
Debt Repayment 0000-2.538000000000-103.16-11.839-1.16
Common Stock Issued 000000000000000.00734.8590
Common Stock Repurchased 0000-0.124-0.124-2.443-2.443000000000
Dividends Paid 00000000000000000
Other Financing Activities -1.531-1.531-1.88-1.88-7.282-7.282-18.847-18.84711.05111.051-2.265-2.2651,288.1991,288.1991,115.78411.334-0.55
Financing Cash Flow -1.531-1.531-1.88-1.88-7.406-7.406-21.29-21.2911.05111.051-2.265-2.2651,288.1991,288.1991,115.79146.193-1.71
Other Information:
Effect Of Forex Changes On Cash -2.016-2.0163.3823.3826.6596.65911.34311.343-30.387-30.387-3.95-3.95-95.162-95.16212.5710.553-0.017
Net Change In Cash -98.245-98.245-314.381-113.367-394.427-134.738-171.23-171.23-189.254-189.254-175.297-175.297968.405968.405796.097-56.684-84.069
Cash At End Of Period -98.245-98.2451,469.321-113.3671,783.7021,723.4431,858.181-171.23-189.2542,389.8952,579.149-175.297968.4051,961.338992.933196.83641.089